The American Academy of Dermatology has established fluid protocols to protect clinicians and patients during the COVID-19 pandemic.

A panel of dermatologists outline how to implement a telehealth structure that allows for sustainable and scalable practice beyond the current crisis.

For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.

In the absence of COVID-19-specific data, published research may serve to guide treatment with biologic agents in patients with psoriasis.

Repeated cycles of treatment with crisaborole may be necessary to achieve and maintain control of atopic dermatitis symptoms.

The American Academy of Dermatology (AAD) has canceled their 2020 annual meeting, which was scheduled to take place from March 20 to 24 in Denver, Colorado. The decision came in light of the restrictions placed on large gatherings, travel, and the closure of public facilities and businesses in an effort to curtail the coronavirus pandemic

Kojic acid is surging in popularity for the treatment of melasma. Jared Jagdeo, MD, reviewed with us his experience treating his patients with kojic acid.

Eli Lilly agreed to buy biopharmaceutical company Dermira, Inc. for $18.75 a share, or approximately $1.1 billion in cash.

Researchers reported on the efficacy of secukinumab in patients with psoriatic arthritis and nail psoriasis and other elements of the disease, including radiographic progression.

Teledermatology offers near-immediate access to specialty medicine for underserved populations. Robert Stavert, MD, MBA, describes the successful physician-to-physician model his team employs at a safety net healthcare system.

In this first report of a head-to-head trial comparing risankizumab and adalimumab, the former agent was found to demonstrate greater efficacy in patients with moderate to severe plaque psoriasis.